These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15056011)

  • 1. Novel 3-oxa lipoxin A4 analogues with enhanced chemical and metabolic stability have anti-inflammatory activity in vivo.
    Guilford WJ; Bauman JG; Skuballa W; Bauer S; Wei GP; Davey D; Schaefer C; Mallari C; Terkelsen J; Tseng JL; Shen J; Subramanyam B; Schottelius AJ; Parkinson JF
    J Med Chem; 2004 Apr; 47(8):2157-65. PubMed ID: 15056011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogs.
    Guilford WJ; Parkinson JF
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):245-50. PubMed ID: 15985364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities.
    O'Sullivan TP; Vallin KS; Shah ST; Fakhry J; Maderna P; Scannell M; Sampaio AL; Perretti M; Godson C; Guiry PJ
    J Med Chem; 2007 Nov; 50(24):5894-902. PubMed ID: 17960922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of methyl (5S,6R,7E,9E,11Z,13E,15S)-16-(4-fluorophenoxy)-5,6,15-trihydroxy-7,9,11,13-hexadecatetraenoate, an analogue of 15R-lipoxin A4.
    Phillips ED; Chang HF; Holmquist CR; McCauley JP
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3223-6. PubMed ID: 12951097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-(5-carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A(2)alpha with reduced lipophilicity: synthesis, biological activity, metabolic stability, solubility, bioavailability, and topical in vivo activity.
    Drews A; Bovens S; Roebrock K; Sunderkötter C; Reinhardt D; Schäfers M; van der Velde A; Schulze Elfringhoff A; Fabian J; Lehr M
    J Med Chem; 2010 Jul; 53(14):5165-78. PubMed ID: 20583844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile.
    Schottelius AJ; Giesen C; Asadullah K; Fierro IM; Colgan SP; Bauman J; Guilford W; Perez HD; Parkinson JF
    J Immunol; 2002 Dec; 169(12):7063-70. PubMed ID: 12471142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism.
    Levy BD; Lukacs NW; Berlin AA; Schmidt B; Guilford WJ; Serhan CN; Parkinson JF
    FASEB J; 2007 Dec; 21(14):3877-84. PubMed ID: 17625069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of topical anti-inflammatory effects of lipoxin A(4) in endotoxin-induced uveitis.
    Medeiros R; Rodrigues GB; Figueiredo CP; Rodrigues EB; Grumman A; Menezes-de-Lima O; Passos GF; Calixto JB
    Mol Pharmacol; 2008 Jul; 74(1):154-61. PubMed ID: 18413658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties.
    Petasis NA; Keledjian R; Sun YP; Nagulapalli KC; Tjonahen E; Yang R; Serhan CN
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1382-7. PubMed ID: 18249111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin.
    Menezes-de-Lima O; Kassuya CA; Nascimento AF; Henriques Md; Calixto JB
    Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):123-35. PubMed ID: 16939877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids co-interact with lipoxin A4 via lipoxin A4 receptor (ALX) up-regulation.
    Hashimoto A; Murakami Y; Kitasato H; Hayashi I; Endo H
    Biomed Pharmacother; 2007 Jan; 61(1):81-5. PubMed ID: 17184966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoxin A(4) metabolites/analogues from two commercial sources have no effects on TNF-alpha-mediated priming or activation through the neutrophil formyl peptide receptors.
    Forsman H; Dahlgren C
    Scand J Immunol; 2009 Oct; 70(4):396-402. PubMed ID: 19751275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration.
    Bannenberg G; Moussignac RL; Gronert K; Devchand PR; Schmidt BA; Guilford WJ; Bauman JG; Subramanyam B; Perez HD; Parkinson JF; Serhan CN
    Br J Pharmacol; 2004 Sep; 143(1):43-52. PubMed ID: 15302682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent.
    Machado FS; Johndrow JE; Esper L; Dias A; Bafica A; Serhan CN; Aliberti J
    Nat Med; 2006 Mar; 12(3):330-4. PubMed ID: 16415877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First total synthesis of structurally unique flavonoids and their strong anti-inflammatory effect.
    Nakatsuka T; Tomimori Y; Fukuda Y; Nukaya H
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3201-3. PubMed ID: 15149675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of pyridine-containing lipoxin A4 analogues.
    Duffy CD; Maderna P; McCarthy C; Loscher CE; Godson C; Guiry PJ
    ChemMedChem; 2010 Apr; 5(4):517-22. PubMed ID: 20127785
    [No Abstract]   [Full Text] [Related]  

  • 17. 5-Cyanopyrimidine derivatives as a novel class of potent, selective, and orally active inhibitors of p38alpha MAP kinase.
    Liu C; Wrobleski ST; Lin J; Ahmed G; Metzger A; Wityak J; Gillooly KM; Shuster DJ; McIntyre KW; Pitt S; Shen DR; Zhang RF; Zhang H; Doweyko AM; Diller D; Henderson I; Barrish JC; Dodd JH; Schieven GL; Leftheris K
    J Med Chem; 2005 Oct; 48(20):6261-70. PubMed ID: 16190753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels.
    Gangemi S; Pescara L; D'Urbano E; Basile G; Nicita-Mauro V; Davì G; Romano M
    Exp Gerontol; 2005 Jul; 40(7):612-4. PubMed ID: 15935589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoxin analogs: novel anti-inflammatory mediators.
    Gewirtz A
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1112-5. PubMed ID: 16312131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.